Dr. Reddy's Laboratories launches public offer to acquire OctoPlus shares
Published on December 14, 2012 at 1:33 AM
Dr. Reddy's Laboratories Limited (NYSE:RDY) ["Dr. Reddy's"], together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus N.V. (Euronext Amsterdam: OCTO), a service-based specialty pharmaceutical company, at an offer price of EUR 0.52 (cum dividend) per share. The Offer Period commences at 14 December 2012 at 09:00 CET and ends on 8 February 2013 at 18:00 CET, unless extended.
Shareholders (including certain members of the Boards) holding in aggregate 63.5% of the issued and outstanding ordinary shares of OctoPlus have entered into irrevocable undertakings to tender their shares under the Offer.
Dr. Reddy's Laboratories Ltd.